Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (7130)	9/2/1998 4:17:00 PM
From: billieo	Read Replies (1) \| Respond to of 17367

So,after all these threads today, and to someone who has a relatively strong position in XOMA at various prices, are all of you saying this is probably a "buy" now or is it a gamble on an acquisition or is it best to perhaps buy into the tax selling for a better 1999? Clearly, if I read all of these messages somewhat correctly, it appears to me most of "you" are quite strong on XOMA and quite knowledgeable and apparently with rather heavy positions. I have to agree that this current price does not bode well by keeping them in the penny stock category. Sorry I can't shed any light on the subject, but thank you all for your comments and seemingly well founded data. Very interesting and encourages me to buy more. Or am I wrong? thanks

To: aknahow who wrote (7130)	9/2/1998 5:28:00 PM
From: JOEBT1	Read Replies (2) \| Respond to of 17367

George--Xoma is not totally blinded to the data. There is an XOMA employee, a statistician, who has the data in addition to the DSMB. So Xoma could choose to stop the trial based on the data. "Theoretically" no other insider is privy to the data.